Upgrade to SI Premium - Free Trial

WAVE Life Sciences (WVE) PT Lowered to $19 at BofA Securities

April 28, 2026 1:13 PM
BofA Securities analyst Alec Stranahan lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $19.00 (from $21.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change